Sedana Medical AB (publ) launches AnaConDa-S
Sedana Medical AB (publ) ("Sedana Medical" or "the Company") is launching AnaConDa-S, a new innovation and an enhancement of its predecessor AnaConDa, in which the ‘dead volume’ has been halved from 100 ml to 50 ml. Halving the dead volume increases the potential market by around 25%. AnaConDa-S is an enhancement of AnaConDa and is designed in a way that enables many more patients, including those with lower lung capacity, to be sedated, which was not possible with the older model. AnaConDa-S expands the target group by around 25 per cent, and the response from the health service